Page last updated: 2024-10-31

moxisylyte and Syncope

moxisylyte has been researched along with Syncope in 1 studies

Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)

Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Norden, LC1

Other Studies

1 other study available for moxisylyte and Syncope

ArticleYear
Adverse reactions to topical ocular autonomic agents.
    Journal of the American Optometric Association, 1978, Volume: 49, Issue:1

    Topics: Atropine; Autonomic Agents; Corneal Diseases; Cyclopentolate; Drug Hypersensitivity; Glaucoma; Human

1978